CHARISSA PARKER: Open Payments
NPI 1225503394 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 4 payments from 4 companies in 2025. Trend: 2023 $2,173 · 2024 $1,601 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 1 | $122 |
| Grifols USA, LLC | 1 | $116 |
| Alnylam Pharmaceuticals Inc. | 1 | $108 |
| Exeltis, USA Inc. | 1 | $103 |
Products named: KRYSTEXXA, Prolastin-C Liquid, AMVUTTRA, TWIRLA.
Industry payments across TX — which companies pay providers there.
